- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
U.S. Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
5
Companies available at a discount paying at least a 2% dividend yield.
5 companies
Johnson & Johnson
Market Cap: US$498.6b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$206.95
7D
-0.3%
1Y
43.5%
Merck
Market Cap: US$261.3b
Operates as a healthcare company worldwide.
MRK
US$105.26
7D
-1.4%
1Y
6.2%
Gilead Sciences
Market Cap: US$152.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$122.74
7D
-1.6%
1Y
34.3%
Pfizer
Market Cap: US$141.6b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE
US$24.90
7D
-0.8%
1Y
-6.4%
Qiagen
Market Cap: US$9.8b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$44.97
7D
-0.9%
1Y
-2.8%